NAD(P)H (quinone acceptor) oxidoreductase (DT-diaphorase)-mediated two-electron reduction of anthraquinone-based antitumour agents and generation of hydroxyl radicals
- 4 February 1992
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 43 (3) , 575-585
- https://doi.org/10.1016/0006-2952(92)90581-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells: Free radical formation and NAD(P)H: Quinone-acceptor oxidoreductase (DT-diaphorase) activityFree Radical Biology & Medicine, 1991
- Enzymology of the reductive bioactivation of SR 4233Biochemical Pharmacology, 1990
- Activation And Deactivation Of Quinones Catalyzed By Dt-Diaphorase. Evidence For Bioreductive Activation Of Diaziquone (Azq) In Human Tumor Cells And Detoxification Of Benzene Metabolites In Bone Marrow StromaFree Radical Research Communications, 1990
- DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs?British Journal of Cancer, 1989
- Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditionsBritish Journal of Cancer, 1989
- The nitroreductase enzyme in walker cells that activates 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) to 5-(aziridin-1-YL)-4-hydroxylamino-2-nitrobenzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2)Biochemical Pharmacology, 1988
- DT-diaphorase activity and the cytotoxicity of quinones in C3H/10T1/2 mouse embryo cellsBiochemical Pharmacology, 1988
- Dicoumarol-sensitive glucuronidation of benzo(a)pyrene metabolites in rat liver microsomesArchives of Biochemistry and Biophysics, 1986
- Mitoxantrone: A New Anticancer Drug with Significant Clinical ActivityAnnals of Internal Medicine, 1986
- DT-diaphorase as a quinone reductase: A cellular control device against semiquinone and superoxide radical formationArchives of Biochemistry and Biophysics, 1982